![NETEC Resource Library](https://repository.netecweb.org/files/theme_uploads/400508e2d5d16a4cdb990b4486af9b3f.png)
Search Instructions:
* Filter the ENTIRE resource library: Choose a OR a to sort all resources.
* Choose Search Items : to filter one collection or perform complex queries.
* Choose Browse by Topic to search by one or more Topics.
Search (686 total)
- Query: COVID
- Query type: Keyword
- Record types:
- Item
- Exhibit
- Simple Page
Record Type | Title | Thumbnail | Subject | Date Published | Description |
---|---|---|---|---|---|
Item | BNT162b2 mRNA Covid-19 Vaccine in a Nationwide Mass Vaccination Setting | Research | 2021-02-24 | As mass vaccination campaigns against coronavirus disease 2019 (Covid-19) commence worldwide, vaccine effectiveness needs to be assessed for a range of outcomes across diverse populations in a noncontrolled setting. In this study, data from Israel’s largest health care organization were used to… | |
Item |
![]() |
Virtual Peer-to-Peer Learning to Enhance and Accelerate the Health System Response to COVID-19: The HHS ASPR Project ECHO COVID-19 Clinical Rounds Initiative | Research | 2021-04-17 | Tasked with identifying digital health solutions to support dynamic learning health systems and their response to COVID-19, the U.S. Department of Health and Human Services Office of the Assistant Secretary for Preparedness and Response partnered with the University of New Mexico's Project ECHO and… |
Item |
![]() |
Bamlanivimab plus Etesevimab in Mild or Moderate Covid-19 | Treatment & Care | 2021-10-07 | Patients with underlying medical conditions are at increased risk for severe coronavirus disease 2019 (Covid-19). Whereas vaccine-derived immunity develops over time, neutralizing monoclonal-antibody treatment provides immediate, passive immunity and may limit disease progression and complications. |
Item |
![]() |
Regional Ebola and Other Special Pathogen Treatment Centers COVID-19 Preparedness and Response Emergency Supplement Performance Measures | General | 2021-03 | Regional Ebola and Other Special Pathogen Treatment Centers COVID-19 Preparedness and Response Emergency Supplement Performance Measures by the U.S. Department of Health and Human Services Office of the Assistant Secretary for Preparedness and Response Hospital Preparedness Program |
Simple Page | Accessible Special Pathogens Timeline | ||||
Item | Can we contain the COVID-19 outbreak with the same measures as for SARS? | Infection Control | 2020-03-05 | The severe acute respiratory syndrome (SARS) outbreak in 2003 resulted in more than 8000 cases and 800 deaths. | |
Item | Using observational data to quantify bias of traveller-derived COVID-19 prevalence estimates in Wuhan, China | Research | 2020-04-01 | The incidence of coronavirus disease 2019 (COVID-19) in Wuhan, China, has been estimated using imported case counts of international travellers, generally under the assumptions that all cases of the disease in travellers have been ascertained and that infection prevalence in travellers and residents… | |
Item | Renin–Angiotensin–Aldosterone System Inhibitors and Risk of Covid-19 | Research | 2020-05-01 | There is concern about the potential of an increased risk related to medications that act on the renin–angiotensin–aldosterone system in patients exposed to coronavirus disease 2019 (Covid-19), because the viral receptor is angiotensin-converting enzyme 2 (ACE2). | |
Item | Genomewide Association Study of Severe Covid-19 with Respiratory Failure | Research | 2020-06-17 | There is considerable variation in disease behavior among patients infected with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes coronavirus disease 2019 (Covid-19). Genomewide association analysis may allow for the identification of potential genetic factors… | |
Item |
![]() |
Rapid implementation of SARS-CoV-2 sequencing to investigate cases of health-care associated COVID-19: a prospective genomic surveillance study | Research | 2020-07-14 | The burden and influence of health-care associated severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections is unknown. We aimed to examine the use of rapid SARS-CoV-2 sequencing combined with detailed epidemiological analysis to investigate health-care associated SARS-CoV-2… |